[Federal Register Volume 62, Number 191 (Thursday, October 2, 1997)]
[Notices]
[Page 51671]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-26167]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting of the National Cancer Institute Special Emphasis Panel (SEP) 
meeting:

    Name of SEP: Efficacy Studies of Chemopreventive Agents in 
animal Models and Evaluation of Chemopreventive Agents by in Vivo 
Screening Assays.
    Date: October 20-21, 1997.
    Time: 8:30 a.m. to 5:00 p.m.
    Place: Double Tree Hotel--Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Courtney M. Kerwin, Ph.D., M.P.H., Scientific 
Review Administrator, National Cancer Institute, NIH, Executive 
Plaza North, Room 630I, 6130 Executive Boulevard, MSC 7405, 
Bethesda, MD 20892-7405, Telephone: 301/496-7421.
    Purpose/Agenda To review and evaluate proposals submitted in 
response to master agreement announcements.
    The meeting will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Proposals 
and the discussions could reveal confidential trade secrets or 
commercial property such as patentable material and personal 
information concerning individuals associated with the proposals, 
the disclosure of which would constitute a clearly unwarranted 
invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control.)

    Dated: September 26, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-26167 Filed 10-1-97; 8:45 am]
BILLING CODE 4140-01-M